Concepedia

G. Scott Pesiridis

GS

Statistics

Publications

8

Citations

1.8K

H-Index

8

Active since

2001

Affiliations

GlaxoSmithKline (United States)(Current)

University of Pennsylvania

University of Massachusetts Chan Medical School

GlaxoSmithKline (Germany)

Howard Hughes Medical Institute

G. Scott Pesiridis is an author at GlaxoSmithKline (United States) specializing in medicine, cell biology, and drug discovery.

ORCID

Top concepts

Publications per year

2001–2023

8

Publications

8

Design of amidobenzimidazole STING receptor agonists with systemic activity

Joshi M. Ramanjulu, G. Scott Pesiridis, Jingsong Yang et al. · Nature · 2018 · 803 citations

, , +4

The Methylosome, a 20S Complex Containing JBP1 and pICln, Produces Dimethylarginine-Modified Sm Proteins

Westley J. Friesen, Sergey Paushkin, Anastasia Wyce et al. · Molecular and Cellular Biology · 2001 · 400 citations · Full text

A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

Fiachra Humphries, Liraz Shmuel-Galia, Zhaozhao Jiang et al. · Science Immunology · 2021 · 156 citations · Full text

A “Two-hit” Hypothesis for Inclusion Formation by Carboxyl-terminal Fragments of TDP-43 Protein Linked to RNA Depletion and Impaired Microtubule-dependent Transport

G. Scott Pesiridis, Kalyan Tripathy, Selcuk A. Tanik et al. · Journal of Biological Chemistry · 2011 · 121 citations · Full text

, , +14

Role of pICLn in Methylation of Sm Proteins by PRMT5

G. Scott Pesiridis, Evan Diamond, Gregory D. Van Duyne · Journal of Biological Chemistry · 2009 · 91 citations · Full text

1–5 of 8